Human iPSC-derived Midbrain Dopaminergic Neurons for Parkinson’s Disease Modeling and Cell Therapy

Описание к видео Human iPSC-derived Midbrain Dopaminergic Neurons for Parkinson’s Disease Modeling and Cell Therapy

Coby Carlson and Chris McMahon from Cellular Dynamics International discuss the development, manufacture and therapeutic research programs incorporating iPSC-derived dopaminergic neurons aimed at therapeutic intervention in Parkinson's disease.

Presented at the Innovation Showcase at the ISSCR Annual Meeting in Boston, MA. June 15, 2017.

Комментарии

Информация по комментариям в разработке